Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Work In Process data on file, last reported at $2.5 million in Q4 2025.

• Work In Process for Q4 2025 came in at $2.5 million, down 45.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (down 45.8% YoY), and the FY2025 annual result was $2.5 million, down 44.15% from the prior year.
• Work In Process fell to $2.5 million in Q4 2025 per ZYBT's latest filing, from $4.6 million in the prior quarter.
• Over five years, Work In Process peaked at $4.7 million in Q4 2023 and troughed at $2.5 million in Q4 2025.
• A 3-year average of $3.9 million and a median of $4.6 million in 2024 frame the typical range for Work In Process.
• The sharpest annual moves came in 2024 and 2025: Work In Process slipped 1.31% in 2024, then tumbled 45.8% in 2025.
• A 3-year view of Work In Process shows it stood at $4.7 million in 2023, then decreased by 1.31% to $4.6 million in 2024, then plunged by 45.8% to $2.5 million in 2025.
• Business Quant data shows ZYBT's Work In Process at $2.5 million in Q4 2025, $4.6 million in Q4 2024, and $4.7 million in Q4 2023.